Ignite Creation Date:
2024-05-06 @ 3:15 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04571918
Status:
RECRUITING
Last Update Posted:
2020-10-01
First Post:
2020-06-29
Brief Title:
Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer
Sponsor:
Oslo University Hospital
Organization:
Oslo University Hospital
Study Overview
Official Title:
Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer a Prospective Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AMRIS
Brief Summary:
Massive rotator cuff tears are common in the adult population It is estimated that about 12 of adults 60 years of age or older suffer from a rotator cuff injury About 40 of these injuries are classified as massive rotator cuff tears MRCT MRCT propose a great challenge to the affected patient and its doctor It is a painful condition with few treatment options
The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far To this date there is only small and non-randomized studies on the subject AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement biceps tenotomy and biodegradable spacer while group B the control group are treated with arthroscopic debridement and biceps tenotomy
The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far To this date there is only small and non-randomized studies on the subject AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement biceps tenotomy and biodegradable spacer while group B the control group are treated with arthroscopic debridement and biceps tenotomy
Detailed Description:
The study is designed as a double blinded randomized controlled trial The physiotherapist responsible for the clinical testing and the patient are both blinded The surgeon knows which group the patient is in but is not responsible for any of the testing We will randomize with envelopes perioperatively The participants are randomized in hence ballon or not ballon In advance of the randomization the surgeon will evaluate if the patient is candidate for partial suture before randomization We plan to stratify the patients with partial suture to ensure homogeneity between the groups
The operation will start with arthroscopic debridement and biceps tenotomy in both groups The patients are thereby evaluated for partial suture and randomized The insertion of the subacromial spacer is done at the end of the operation for those patients randomized to the group balloon Peroperatively the surgeon will classify the grade of osteoarthritis with Outerbridge classification and the state of the rotator cuff and the long head of the biceps tendon
Postoperative mobilization will be the following
0-2 weeks Immobilization in a sling The participant is advised to do simple exercises for shoulder mobilization Restriction of movement above shoulder level
2-6 weeks Free mobilization Advised to avoid heavy lifting
6-12 weeks Work on increasing range of motion gradually introduce weight lifting
The operation will start with arthroscopic debridement and biceps tenotomy in both groups The patients are thereby evaluated for partial suture and randomized The insertion of the subacromial spacer is done at the end of the operation for those patients randomized to the group balloon Peroperatively the surgeon will classify the grade of osteoarthritis with Outerbridge classification and the state of the rotator cuff and the long head of the biceps tendon
Postoperative mobilization will be the following
0-2 weeks Immobilization in a sling The participant is advised to do simple exercises for shoulder mobilization Restriction of movement above shoulder level
2-6 weeks Free mobilization Advised to avoid heavy lifting
6-12 weeks Work on increasing range of motion gradually introduce weight lifting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None